• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

花粉提取物免疫疗法局部和全身反应的前瞻性调查。

Prospective survey of local and systemic reactions to immunotherapy with pollen extracts.

作者信息

Nelson B L, Dupont L A, Reid M J

出版信息

Ann Allergy. 1986 Apr;56(4):331-4.

PMID:3963525
Abstract

To assess the relative risk of local and systemic reactions to injections of pollen extracts and to examine the predictive value of these local reactions for systemic reactions, a prospective survey of local and systemic reactions was performed from October 1981 to June 1983 at a large military allergy clinic. Four hundred and sixteen patients received 26,645 injections of pollen extracts. Of the total, 25,508 injections (95.7%) were not associated with reactions, 1,055 injections (4.0%) were associated with local reactions (669, less than 2 cm in diameter; 279, 2 to 5 cm; and 107 greater than 5 cm), and 82 injections (0.3%) were associated with systemic reactions. Seventy patients experienced 82 systemic reactions. Of these, 25 (36%) had no prior local reactions. Eighteen males and 52 females had systemic reactions. The sensitivity of local reactions as a predictor of systemic reactions was 64%, the specificity was 1.2%, the positive predictive value was 12%, and the negative predictive value was 14%. Proportionally, more women than men experienced systemic reactions, P less than 0.05. We made the following conclusions. Most injections of pollen extracts were not associated with local or systemic reactions. The majority of reactions were local. The presence of local reactions was not helpful in predicting which patients would develop systemic reactions. Women appeared to be at greater risk for systemic reactions than men.

摘要

为评估注射花粉提取物后发生局部和全身反应的相对风险,并检验这些局部反应对全身反应的预测价值,1981年10月至1983年6月在一家大型军事过敏诊所对局部和全身反应进行了一项前瞻性调查。416名患者接受了26645次花粉提取物注射。其中,25508次注射(95.7%)未出现反应,1055次注射(4.0%)出现局部反应(669次,直径小于2厘米;279次,2至5厘米;107次大于5厘米),82次注射(0.3%)出现全身反应。70名患者经历了82次全身反应。其中,25名(36%)之前没有局部反应。18名男性和52名女性出现全身反应。局部反应作为全身反应预测指标的敏感性为64%,特异性为1.2%,阳性预测值为12%,阴性预测值为14%。按比例计算,出现全身反应的女性多于男性,P<0.05。我们得出以下结论。大多数花粉提取物注射未出现局部或全身反应。大多数反应为局部反应。局部反应的出现无助于预测哪些患者会发生全身反应。女性发生全身反应的风险似乎高于男性。

相似文献

1
Prospective survey of local and systemic reactions to immunotherapy with pollen extracts.花粉提取物免疫疗法局部和全身反应的前瞻性调查。
Ann Allergy. 1986 Apr;56(4):331-4.
2
Local and systemic reactions during immunotherapy with adsorbed extracts of house dust mite in children.儿童使用屋尘螨吸附提取物进行免疫治疗期间的局部和全身反应。
Ann Allergy Asthma Immunol. 2000 Oct;85(4):317-21. doi: 10.1016/S1081-1206(10)62536-7.
3
Safety of immunotherapy with therapeutic vaccines containing depigmented and polymerized allergen extracts.含脱色素和聚合变应原提取物的治疗性疫苗免疫疗法的安全性。
Clin Exp Allergy. 2007 Mar;37(3):434-40. doi: 10.1111/j.1365-2222.2007.02667.x.
4
Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy.皮下变应原免疫治疗期间全身反应者中局部大反应的频率增加。
Ann Allergy Asthma Immunol. 2007 Jul;99(1):82-6. doi: 10.1016/S1081-1206(10)60626-6.
5
Nonfatal systemic allergic reactions induced by skin testing and immunotherapy.
Ann Allergy. 1993 Dec;71(6):557-62.
6
The LOCAL Study: Local reactions do not predict local reactions in allergen immunotherapy.局部反应研究:在变应原免疫治疗中,局部反应无法预测局部反应。
J Allergy Clin Immunol. 2009 Oct;124(4):739-44. doi: 10.1016/j.jaci.2009.07.048. Epub 2009 Sep 19.
7
Allergen vial mixing and immunotherapy: Risks of infections and vial contamination.变应原小瓶混合与免疫疗法:感染及小瓶污染风险
Otolaryngol Head Neck Surg. 2007 Aug;137(2):243-5. doi: 10.1016/j.otohns.2007.02.012.
8
Local reactions during allergen immunotherapy do not require dose adjustment.变应原免疫治疗期间的局部反应无需调整剂量。
J Allergy Clin Immunol. 2000 Nov;106(5):840-3. doi: 10.1067/mai.2000.110468.
9
Systemic reactions due to allergen immunotherapy.
J Investig Allergol Clin Immunol. 1999 Jan-Feb;9(1):39-44.
10
Premedication reduces the incidence of systemic reactions during inhalant rush immunotherapy with mixtures of allergenic extracts.预处理可降低使用变应原提取物混合物进行吸入式急速免疫疗法期间全身反应的发生率。
Ann Allergy. 1994 Nov;73(5):409-18.

引用本文的文献

1
Clinical Practice Guideline: Immunotherapy for Inhalant Allergy.临床实践指南:变应原吸入性免疫疗法。
Otolaryngol Head Neck Surg. 2024 Mar;170 Suppl 1(Suppl 1):S1-S42. doi: 10.1002/ohn.648.
2
Safety Profile and Issues of Subcutaneous Immunotherapy in the Treatment of Children with Allergic Rhinitis.皮下免疫疗法治疗儿童变应性鼻炎的安全性特征和问题。
Cells. 2022 May 9;11(9):1584. doi: 10.3390/cells11091584.
3
Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases.屋尘螨皮下免疫治疗在学龄前呼吸道过敏性疾病儿童中的安全性。
Ital J Pediatr. 2021 Apr 23;47(1):101. doi: 10.1186/s13052-021-01046-z.
4
Adverse reactions to subcutaneous immunotherapy in patients with allergic rhinitis, a real-world study.变应性鼻炎患者皮下免疫治疗的不良反应:一项真实世界研究。
Eur Arch Otorhinolaryngol. 2021 Nov;278(11):4353-4360. doi: 10.1007/s00405-021-06736-2. Epub 2021 Mar 13.
5
Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis.中华医学会变态反应学分会变应性鼻炎诊断和治疗指南
Allergy Asthma Immunol Res. 2018 Jul;10(4):300-353. doi: 10.4168/aair.2018.10.4.300.
6
Chinese Guideline on allergen immunotherapy for allergic rhinitis.变应性鼻炎变应原特异性免疫治疗中国专家共识
J Thorac Dis. 2017 Nov;9(11):4607-4650. doi: 10.21037/jtd.2017.10.112.
7
Allergen immunotherapy: an updated review of safety.变应原免疫疗法:安全性的最新综述。
Curr Opin Allergy Clin Immunol. 2017 Feb;17(1):55-59. doi: 10.1097/ACI.0000000000000335.
8
How should allergists deal with local reactions to allergen immunotherapy?变应原免疫治疗的局部反应,过敏科医生该如何应对?
Curr Allergy Asthma Rep. 2011 Apr;11(2):115-21. doi: 10.1007/s11882-010-0172-5.
9
The local and systemic side-effects of venom and inhaled-allergen subcutaneous immunotherapy.毒液和吸入性变应原皮下免疫疗法的局部和全身副作用。
Wien Klin Wochenschr. 2009;121(9-10):357-60. doi: 10.1007/s00508-009-1172-0.
10
Safety considerations in assessing the role of immunotherapy in allergic disorders.评估免疫疗法在过敏性疾病中的作用时的安全性考量
Drug Saf. 1994 Jan;10(1):5-17. doi: 10.2165/00002018-199410010-00002.